Medicine

The Neurobiochemistry Laboratory at AIIMS Delhi has launched a new Therapeutic Drug Monitoring facility to improve epilepsy care. The service aims to provide affordable testing for patients across India. Officials said it will help optimise treatment and reduce reliance on costly private labs.

9 Mwezi wa tano, 2026 Imeripotiwa na AI Imethibitishwa ukweli

Researchers comparing appendage regrowth in salamanders, fish and mice report that two related genes, SP6 and SP8, are activated in regenerating skin tissue across species and are required for normal bone regrowth in animal models—findings they say could inform future regenerative-medicine strategies.

A major Cochrane review of 17 clinical trials involving over 20,000 participants has concluded that drugs targeting amyloid beta in the brain provide no meaningful benefits for patients with mild cognitive impairment or early Alzheimer’s. These treatments also raise the risk of brain swelling and bleeding. Researchers urge a shift to alternative pathways for future treatments.

1 Mwezi wa tano, 2026 Imeripotiwa na AI Imethibitishwa ukweli

In a two-year U.S. trial of 1,658 adolescents and adults with prior kidney stones, a technology-assisted hydration program modestly increased urine output but did not significantly reduce symptomatic stone recurrences compared with standard care.

A 15-year-old girl in Nepal experienced large, rubbery keloids emerging from her chickenpox scars, in what doctors describe as only the sixth documented case worldwide. The growths appeared suddenly on her jaw, chest, abdomen, and flank after she recovered from the infection. Her case appears in the journal Clinical Case Reports.

24 Mwezi wa nne, 2026 Imeripotiwa na AI

A study involving 73 people with mild cognitive impairment or early dementia found that tailored treatment plans targeting nutritional deficiencies, infections and other factors led to significant cognitive improvements after nine months. Participants in the intervention group saw their overall cognitive scores rise by 13.7 points, while the control group declined by 4.5 points. The approach combines medical interventions with lifestyle changes like diet, exercise and cognitive training.